Four members of globomycin, SF-1902 A2, A3, A,e and A4b were newly isolated from the culture of Streptomyces hygroscopicus SF-1902. These minor components shared four amino acids in common and the fifth was either valine or allo-isoleucine.
In our screening of new antibiotics, a novel neutral antibiotic complex, SF-1902 A group was isolated from the culture of Streptomyces hygroscopicus SF-1902. The complex contained about ten components in which A1* identical with globomycin') was dominant. From the minor components so far five, A,, A3, A4a, A,b and A, were characterized in this laboratory.
Isolation and structure of SF-1902 A5 were reported previously'). In this paper, we wish to describe isolation and structures of SF-1902 A2i A3, A4a and A4b as well as structure-activity relationship among them. Characterization of the producing organism and its fermentation have already been reported').
Isolation and Purification of Minor Components
The SF-1902 complex was a neutral and solvent soluble material, which could be extracted with ethyl acetate from the fermentation broth and with acetone from the mycelia. SF-1902 A4ai A4b and A, (A4;,, A4b and A5) were minute in broth filtrates but substantial amounts (0 8 %) of these components were found in the organic extract from mycelia.
Isolation of SF-1902 complex was effected by repeated chromatography over silica gel followed by crystallization from aqueous acetonitrile. A crystalline complex thus obtained contained 70% of globomycin (SF-1902 A1). The minor components were relatively concentrated in the mother liquor, as However, in methanol-d4 or in case of diacetate, these carbons showed sharp signals (WI /2 -15Hz), suggesting the conformational isomerism involving hydrogen bonding. Table 4 . The site of lactone ring formation was considered to be identical with that in Al from the similarity of CMR. These results lead to the structures shown in Fig. 1 for the minor components of SF-1902. Thus, A, shared five amino acids in common with A1, but the fatty acid alkyl chain was shorter than that of A, by two methylenes. A, shared four amino acids in common with Al and allo-isoluecine was replaced by valine. The fatty acid in A, was identical with that in A1. A4a . shared five amino acids in common with A1, but the fatty acid contained one more carbon than that of A1. A4b shared five amino acids in common with A3, but the fatty acid contained two more carbons than that of A1.
Biological Properties
Antibacterial spectra of A,-Alb were compared with those of A, and A5. They were active against Gram-negative bacteria, but not against Gram-positive bacteria. Of particular interest was that the antibacterial activity is quite sensitive to the length of alkyl side chain, either in a fatty acid or in an amino acid, as shown in Table 5 . Replacement of valine with allo-isoleucine, resulting in single carbon increment, exerted 2 to 4 fold decrease in MIC value. As seen between globomycin (A1) and A4a or between A,, and A5, single carbon increase in a fatty acid side chain resulted in also 2 to 4 fold activity enhancement. SF-1902 A5 which had the longest side chain showed the highest antibacterial activity. A,, with the shortest side chain showed the weakest activity, though it still exhibited considerable activity against Salmonella interitidis and Shigella flexneri. Globomycin (SF-1902A,) was intermediate in both Since acetylation of hydroxyl groups in serine and allo-threonine diminished activity, the two hydroxyl groups seem to be essential for antibacterial activity. However, the diphosphate of globomycin in which hydroxyl groups of serine and allo-threonine were phosphorylated retained antibacterial activity to some selected bacteria (MIC; 12.5 mcg/ml against Escherichia coli W3630 RGN 823, and 25 mcg/ml against Shigella sonntei EW 33 Type I). On the other hand mono-phosphate (Ser) showed no antibacterial activity. Open chain compounds (seco-acids) also completely lost bioactivity. These results indicate that the presence of long side chain of lipophilic nature and a cyclic structure with inner hydrophilic hole are essential for the antibacterial activity of globomycin analogues.
INUKAI et al. reported that globomycin inhibited the prolipoprotein processing enzyme of Gramnegative bacteria'). Since the new analogues of globomycin probably possess the same mechanism of action, these new antibiotics, especially A5 will be suitable tools in the study of bacterial lipoprotein synthesis in outer membrane.
Intraperitoneal administration of each component at a dose of 180 mg/kg caused no death of mice.
Ex perimentals
HPLC Analysis HPLC analysis of SF-1902 minor components was carried out on Nucleosil 5C18 (4.6 111m.: 150 mm), fLBondapak C18 (4.6 mm x 250 mm) or Develosil ODS-7 (Nomura Kagaku, Osaka) (4.6 mm X250 mm) developed with 60-70% aqueous acetonitrile. Components were detected with a UV detector at 220 nm.
Separation of Four Products a) Preliminary separation:
Crude extract (16 g) was applied to silica gel column (Wako-gel C-300, 40 mm x 250 mm) and developed with a mixture of chloroform -methanol (40: 1 -20: 1) (flow rate: 6-10 ml/minute, 1025 kg/cm2). Biologically active effluents were divided roughly into three fractions after HPLC analysis. Most of A, was distributed in the first fraction (1.7 g; A,B+A,b: 3 %, A5: 36%, globomycin: 42%). A2 and A3 were concentrated in the third fraction (4.5 g; A2: 5%, A3: 26%, globomycin : 45%). The second fraction gave crystalline globomycin containing less than 10 of minors. After concentration, followed by addition of acetonitrile, all three fractions afforded crystalline mixture of SF-1902 components. Separation of minor components by fractional crystallization failed.
b) Complete separation: 1) A sample of the first fraction (1.7 g) was chromatographed over LiChroprep RP-8 (25 -40 It, E. Merck) column (40 mm x 250 mm) and developed with 55 % aqueous acetonitrile (4.5 ml/minute; 20 kg/cm2). Pure components except A, and A,b were obtained by this methods. Separation of A,, from A,b was still incomplete under this condition. A, mixture sample (51 mg) was chromatographed over Nucleosil 5C18 (10 mm x 250 mm) and eluted with 70 % aqueous acetonitrile (2.0 ml/minute; 120 kg/cm2) to carry out the final separation. Complete separation of A,,, from Alb needed repeated chromatography over the same column.
2) A sample of the third fraction (4.5 g) was chromatographed over Nucleosil 5C18 (10 mm, s 250 mm) and developed with 60 % aqueous acetonitrile (1.3 -1.7 ml/minute; 55 -78 kg/cm2), in order to obtain pure samples of A2 and A3. Each component was finally purified by recrystallization from 60 % aqueous acetonitrile.
Isolation of Optically Active N-Methylleucine A sample of a minor component (300 mg) was hydrolyzed in 4 m methanesulfonic acid (30 ml) containing 0.2% tryptamine at 110°C for 20 hours. After neutralization by aqueous NaOH, the hydrolysate was passed through a small column of Dowex 50W-x 2 (H+), which was washed with water followed by elution with 0.5 N NH,OH.
After concentration, the eluate was subjected to chromatography VOL. [a]' =31.3° (c 0.9, 5 N HCl)3'). Permethylation of Seco-acid To a solution of seco-acid of a minor component (3-5 mg) in freshly distilled dry DMSO (2 ml) was added methylsulfinyl carbanion in DMSO (0.5 ml; prepared from NaH; 50%, 200 mg and DMSO; 2 ml) under nitrogen. After 15 minutes at room temperature, 200 id of CH3I was carefully added and stirred for 2 hours. After usual work-up, the product was subjected to MS-analysis.
Preparation of Mono-and Di-phosphates Globomycin (SF-1902 A1) (2.0 g) was reacted with diphenylphosphorochloridate (2.43 g) in dry pyridine (45 ml) at -20°C for 2 hours. The reaction product, after ethyl acetate extraction and concentration, was immediately subjected to catalytic hydrogenolysis for 2.5 hours. Pt02 (500 mg) was used in 70% aqueous ethanol (200 ml) containing acetic acid (0.5 ml). After usual work-up, the product was subjected to silica gel column chromatography (CHC13 -MeOH=10 
